AzTrials
AzTrials

RecessionNCT03232788

Use of Scaffolds for Treatment of Gingival Recession Associated With Interproximal Tissue Deficiency

A study testing Bone regeneration, Collagen membrane and Scaffold in people with Recession and Periodontal Diseases, run by University of Sao Paulo at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will seek to evaluate the predictability and efficacy of a Computer Aided Design-Computer Aided Manufacturing and additively manufactured polycaprolactone and hydroxyapatite scaffolds in these defects compared to traditional guided tissue regeneration. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Recession, Periodontal Diseases
What is being tested?
Bone regeneration, Collagen membrane and Scaffold
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteBrazil
Study dates
1 Apr 2017to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Presenting at least two single-rooted teeth with Miller's Class III and IV recessions with Norland \& Tarnow class I, II or III papilla deficiency

Who cannot join

  • History of periodontal surgery at the area on the last 12 months
  • Use of drugs that affect periodontal tissues (eg: anticonvulsants, calcium channel blockers, cyclosporine, bisphosphonates, hormone-based contraceptives, steroids)
  • Pregnant
  • Smokers
  • Diabetics
  • History of head and neck radiotherapy
Show all 11Show fewer
  • Teeth without adjacent mesial and distal contact
  • Teeth with mobility
  • Malpositioned teeth
  • Teeth with endodontic treatment
  • Teeth without a visible cementoenamel junction

Trial locations and contacts

1 site in 1 country.

Vitor T Stuani, PhD contact

+55 (18) 99748-7279

vitortoledo@usp.br

Brazil1 site, 1 recruiting
  • Bauru School of Dentistry - University of Sao Paulo

    Bauru, São Paulo, 17012-901

    Vitor T Stuani, MSc, +55 (18) 99748-7279, vitortoledo@usp.br

    Vitor T Stuani, MSc

    Recruiting

Other trials in Brazil

About this study

Official title: Use of Computer Aided Design-Computer Aided Manufacturing and Additively Manufactured Scaffolds for Treatment of Gingival Recession Associated With Interproximal Tissue Deficiency

This study will seek to evaluate the predictability and efficacy of a Computer Aided Design-Computer Aided Manufacturing and additively manufactured polycaprolactone and hydroxyapatite scaffolds in these defects compared to traditional guided tissue regeneration. 40 gingival recessions associated with interproximal tissue deficiency will be divided into two groups: control group (autogenous bone + collagen membrane; n = 20) and test group (autogenous bone + scaffold; n = 20).

Read the detailed description

The treatment of gingival recessions associated with interproximal bone and gingival tissue deficiency, and also the absence of interdental papilla, are major challenges within the periodontics due to lacking predictability. However, an intervention in these cases is extremely important, since the presence of these defects is associated with aesthetic, phonetic, hypersensitivity and may be associated with other dental damages. This study will seek to evaluate the predictability and efficacy of a Computer Aided Design-Computer Aided Manufacturing and additively manufactured polycaprolactone and hydroxyapatite scaffolds in these defects compared to traditional guided tissue regeneration. 40 gingival recessions associated with interproximal tissue deficiency will be divided into two groups: control group (autogenous bone + collagen membrane; n = 20) and test group (autogenous bone + scaffold; n = 20). A split-mouth design will be used with both procedures performed at the same surgical time.

Being tested
Bone regeneration, Collagen membrane, Scaffold
Keywords
Periodontal disease, Recession, Black space
Medical subject headings
Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bone regenerationProcedure or surgery

    Autogenous bone will be placed over periodontal defect after root treatment with scaling and root planing.

  • Collagen membraneDevice

    A collagen membrane will be used to cover the autogenous bone.

  • ScaffoldDevice

    A hydroxyapatite and polycaprolactone scaffolds will be used to cover the autogenous bone.

Study groups in NCT03232788
Study groupRoleWhat they receive
Test groupExperimentalBone regeneration with autogenous bone + scaffold.
Receives: Procedure: Bone regeneration; Device: Scaffold
Control groupActive comparatorBone regeneration with autogenous bone + collagen membrane.
Receives: Procedure: Bone regeneration; Device: Collagen membrane

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total root coverage measured with a periodontal probe in millimeters

    Ideal if the distance from cemento-enamel junction to gingival margin = 0 mm

    Measured: One year

  2. Total interdental papilla formation measured with a periodontal probe in mm

    Ideal if the distance from dental contact point to interdental papilla top = 0 mm

    Measured: One year

Secondary outcomes (9)
  1. Depth of probing measured with a periodontal probe in millimeters

    The distance from gingival margin and the apical point of gingival pocket or sulcus

    Measured: One year

  2. Clinical attachment level measured with a periodontal probe in millimeters

    The distance from cemento-enamel junction and the apical point of gingival pocket or sulcus

    Measured: One year

  3. Gingival bleeding index measured with a periodontal probe

    Evaluated by the presence or absence of bleeding after probing

    Measured: One year

  4. Radiographic bone formation measured digitally in millimeters

    The distance from interdental bone crest and cemento-enamel junction

    Measured: One year

  5. Tomographic bone formation measured digitally in cubic millimeters

    The variation of bone volume observed by tomography digital reconstruction

    Measured: One year

  6. Evaluation of pink aesthetics by professionals using the Pink Esthetic Score

    Photographic evaluation of gingival aesthetics during the treatment done by blinded periodontists.

    Measured: One year

  7. Patient's evaluation of aesthetics using a visual analogue scale

    Patient's aesthetic evaluation with a score ranging from 0 (terrible aesthetic) to 10 (excellent aesthetic)

    Measured: One year

  8. Patient's evaluation of dental sensibility using a visual analogue scale

    Patient's dental sensibility evaluation with a score ranging from 0 (no sensibility) to 10 (intense sensibility)

    Measured: One year

  9. Patient's evaluation of post-operatory pain using a visual analogue scale

    Patient's post-operatory pain evaluation with a score ranging from 0 (no pain) to 10 (intense pain)

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2017
  2. Study start1 Apr 2017
  3. Primary completionJul 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03232788
Sponsor's protocol ID
FOB3DPrint1
Status last verified
Jul 2017
First submitted
23 Jul 2017
Last updated
28 Jul 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Bone regeneration, Collagen membrane and Scaffold in people with Recession and Periodontal Diseases, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Vitor T Stuani, PhD (+55 (18) 99748-7279, vitortoledo@usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total root coverage measured with a periodontal probe in millimeters (time frame: One year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in